Anaemia is common after kidney transplantation, especially among African Americans

被引:44
作者
Shibagaki, Y [1 ]
Shetty, A [1 ]
机构
[1] Henry Ford Hosp, Div Nephrol & Hypertens, Detroit, MI 48202 USA
关键词
anaemia; African American race; female; kidney transplantation; multivariate analysis;
D O I
10.1093/ndt/gfh256
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Anaemia is a major cardiovascular risk factor in renal disease. It might be appropriate to extrapolate this association of anaemia with cardiovascular disease to renal transplant recipients who continue to have a significant cardiovascular risk. There are very few studies addressing the issue of anaemia after renal transplantation. Methods. We studied 192 consecutive kidney transplant recipients over a 5-year period in a tertiary referral centre in Michigan, USA. Patients who were followed up at the ambulatory transplant clinic for at least 1 year after transplantation were studied. Haemoglobin (Hb) level at 6 months and 1 year after renal transplantation was recorded. Risk factors for anaemia were evaluated using multivariate regression analysis. Results. Significant anaemia (Hb <11 g/dl in females and 12g/dl in males) was common (19.3% at 6 months, 19.8% at 1 year). Anaemia was more common in African American (AA) than in non-AA patients both at 6 months and 1 year after transplantation. Multivariate analysis showed that serum creatinine was an independent risk factor for anaemia. Female gender was associated with significant anaemia at 1 year. Intriguingly, AA race was also an independent risk factor at 6 months and strong trend for risk at 1 year. Conclusions. Anaemia is common during the first year after kidney transplantation. AA race as well as high serum creatinine and female gender are independent risk factors for post-transplant anaemia. The importance of anaemia as a risk factor in AA patients after renal transplantation should be more recognised.
引用
收藏
页码:2368 / 2373
页数:6
相关论文
共 20 条
  • [1] Behrend M, 1999, TRANSPLANTATION, V68, P391
  • [2] DYNAMICS OF ERYTHROPOIESIS FOLLOWING RENAL-TRANSPLANTATION
    BESARAB, A
    CARO, J
    JARRELL, BE
    FRANCOS, G
    ERSLEV, AJ
    [J]. KIDNEY INTERNATIONAL, 1987, 32 (04) : 526 - 536
  • [3] The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Murray, DC
    Barre, PE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) : 53 - 61
  • [4] Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature
    Geetha, D
    Zachary, JB
    Baldado, HM
    Kronz, JD
    Kraus, ES
    [J]. CLINICAL TRANSPLANTATION, 2000, 14 (06) : 586 - 591
  • [5] ANEMIA IN RENAL-TRANSPLANT RECIPIENTS CAUSED BY CONCOMITANT THERAPY WITH AZATHIOPRINE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    GOSSMANN, J
    KACHEL, HG
    SCHOEPPE, W
    SCHEUERMANN, EH
    [J]. TRANSPLANTATION, 1993, 56 (03) : 585 - 589
  • [6] Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
    Hayashi, T
    Suzuki, A
    Shoji, T
    Togawa, M
    Okada, N
    Tsubakihara, Y
    Imai, E
    Hori, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) : 250 - 256
  • [7] Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study
    Holland, DC
    Lam, M
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (05) : 650 - 658
  • [8] ANALYSIS OF THE QUANTITATIVE RELATIONSHIP BETWEEN ANEMIA AND CHRONIC RENAL-FAILURE
    HOWARD, AD
    MOORE, J
    WELCH, PG
    GOUGE, SF
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1989, 297 (05) : 309 - 313
  • [9] Katznelson S, 1995, Clin Transpl, P379
  • [10] Lorenz M, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133794